U. Holwerda

Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders.

I. T. de Almeida, M. Durán, B. Poll-The, 1998, Clinical chemistry.

5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers.

G. Peters, S. Meijer, C. L. van der Wilt, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

The Effect of Food on the Pharmacokinetics of S-1 after Single Oral Administration to Patients with Solid Tumors

G. Peters, G. Giaccone, J. Schellens, 2004, Clinical Cancer Research.

Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors

G. Peters, G. Giaccone, J. Wanders, 2003, Cancer Chemotherapy and Pharmacology.

Guanidinoacetate Methyltransferase Activity in Lymphocytes, for a Fast Diagnosis.

E. Struys, G. Salomons, E. Jansen, 2017, JIMD reports.

A pilot study to estimate incidence of guanidinoacetate methyltransferase deficiency in newborns by direct sequencing of the GAMT gene.

J. Loeber, A. Pop, W. Kanhai, 2016, Gene.

Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse.

H. Pinedo, W. van der Vijgh, U. Holwerda, 1992, Cancer research.

The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin.

H. Pinedo, W. van der Vijgh, I. Klein, 1991, Biochemical pharmacology.

A Non‐Radioactive Sensitive Assay to Measure 5‐Fluorouracil Incorporation into DNA of Solid Tumors

G. Peters, C. L. van der Wilt, P. Noordhuis, 2004, Nucleosides, nucleotides & nucleic acids.

Quantification of 5-fluorouracil incorporation into RNA of human and murine tumors as measured with a sensitive gas chromatography-mass spectrometry assay.

C. L. van der Wilt, H. Pinedo, P. Noordhuis, 1995, Analytical biochemistry.

Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS.

H. J. Brink, M. Durán, C. Jakobs, 2000, Journal of pharmaceutical and biomedical analysis.